Comparison of the Effectiveness of Metacognitive Therapy and Behavioral Activation on Executive Functions of Elderly People with Type 2 Diabetes

Document Type : Original Article

Authors

1 Ph.D. Student of Psychology, Department of Psychology, Semnan Branch, Islamic Azad University, Semnan, Iran.

2 Associate Professor, Department of Psychology, Semnan Branch, Islamic Azad University, Semnan, Iran.

3 Associate Professor, Department of Psychology, Faculty of Psychology, Allameh Tabataba'i University, Tehran, Iran.

4 Associate Professor, Department of Educational Psychology, Faculty of psychology and Education, Allameh Tabataba'i University, Tehran, Iran.

Abstract

Background: Diabetes mellitus is a metabolic disorder in the body whose prevalence is constantly increasing.

Objectives: The aim of this study was to compare the effectiveness of metacognitive therapy and behavioral activation on executive functions of elderly people with type 2 diabetes.

Methods: This study was a quasi-experimental study with pretest, posttest, and control group design, and a three-month follow-up. The statistical population included people with type 2 diabetes who were referred to five endocrine clinics located in area 11 and were at least 60 years old and 75 years old at most. Forty-five women and men participated in this study through a purposeful and voluntary sampling method. Wisconsin card was used for data collection. Data were analyzed using descriptive statistics such as mean and standard deviation and inferential statistics by analysis of covariance and repeated measure ANOVA with SPSS.25 software.

Results: The results showed that show that there is no statistically significant difference between metacognitive and behavioral activation groups in the subscales of executive function, and the mean post-test of the groups is almost equal (p <0.05). Correct reaction time, first patterns attempt were significantly different compared to the control group (P>0.05).

Conclusion: It can be concluded that meta-cognitive therapy and behavioral activation increased effective executive functions.

Keywords

Open Access Policy: This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. To view a copy of this licence, visit https://creativecommons.org/licenses/by/4.0/

References

1. Sacco WP, Bykowski CA. Depression and hemoglobin A1c in type 1 and type 2 diabetes: the role of self-efficacy. Diabetes research and clinical practice. 2010;90(2):141-6.
https://doi.org/10.1016/j.diabres.2010.06.026
PMid:20673594
 
2. Wang J, He M, Zhao X. Depressive symptoms, family functioning and quality of life in Chinese patients with type 2 diabetes. Canadian journal of diabetes. 2015;39(6):507-12.
https://doi.org/10.1016/j.jcjd.2015.06.001
PMid:26297526
 
3. Owens-Gary MD, Zhang X, Jawanda S, Bullard KM, Allweiss P, Smith BD. The Importance of Addressing Depression and Diabetes Distress in Adults with Type 2 Diabetes. Journal of General Internal Medicine. 2019;34(2):320-4.
https://doi.org/10.1007/s11606-018-4705-2
PMid:30350030 PMCid:PMC6374277
 
4. Basu S, Sharma N. Diabetes self-care in primary health facilities in India-challenges and the way forward. World journal of diabetes. 2019;10(6):341.
https://doi.org/10.4239/wjd.v10.i6.341
PMid:31231457 PMCid:PMC6571487
 
5. Kim MY, Lee EJ. Factors affecting self-care behavior levels among elderly patients with type 2 diabetes: A quantile regression approach. Medicina. 2019;55(7):340.
https://doi.org/10.3390/medicina55070340
PMid:31277522 PMCid:PMC6681195
 
6. Owens-Gary MD, Zhang X, Jawanda S, Bullard KM, Allweiss P, Smith BD. The Importance of Addressing Depression and Diabetes Distress in Adults with Type 2 Diabetes. Journal of General Internal Medicine. 2019;34(2):320-4.
https://doi.org/10.1007/s11606-018-4705-2
PMid:30350030 PMCid:PMC6374277
 
7. Schinckus L, Dangoisse F, Van den Broucke S, Mikolajczak M. When knowing is not enough: Emotional distress and depression reduce the positive effects of health literacy on diabetes self-management. Patient education and counseling. 2018 Feb 1;101(2):324-30.
https://doi.org/10.1016/j.pec.2017.08.006
PMid:28855062
 
8. Bottonari KA, Roberts JE, Thomas SN, Read JP. Stop thinking and start doing: Switching from cognitive therapy to behavioral activation in a case of chronic treatment-resistant depression. Cognitive and Behavioral Practice. 2008 Nov 1;15(4):376-86.
https://doi.org/10.1016/j.cbpra.2008.02.005
 
9. Daughters SB, Braun AR, Sargeant MN, Reynolds EK, Hopko DR, Blanco C, Lejuez CW. Effectiveness of a brief behavioral treatment for inner-city illicit drug users with elevated depressive symptoms: the life enhancement treatment for substance use (LETS Act!). Journal of Clinical Psychiatry. 2008 Jan 1;69(1):122.
https://doi.org/10.4088/JCP.v69n0116
PMid:18312046
 
10. Baruch DE, Kanter JW, Bowe WM, Pfennig SL. Improving homework compliance in career counseling with a behavioral activation functional assessment procedure: a pilot study. Cognitive and Behavioral Practice. 2011 May 1;18(2):256-66.
https://doi.org/10.1016/j.cbpra.2010.04.003
 
11. Hagen R, Hjemdal O, Solem S, Kennair LE, Nordahl HM, Fisher P, Wells A. Metacognitive therapy for depression in adults: a waiting list randomized controlled trial with six months follow-up. Frontiers in psychology. 2017 Jan 24;8:31.
https://doi.org/10.3389/fpsyg.2017.00031
 
12. Normann N, van Emmerik AA, Morina N. The efficacy of metacognitive therapy for anxiety and depression: A meta‐analytic review. Depression and Anxiety. 2014 May;31(5):402-11.
https://doi.org/10.1002/da.22273
PMid:24756930
 
13. Jelinek L, Van Quaquebeke N, Moritz S. Cognitive and metacognitive mechanisms of change in metacognitive training for depression. Scientific reports. 2017 Jun 14;7(1):3449.
https://doi.org/10.1038/s41598-017-03626-8
PMid:28615651 PMCid:PMC5471213
 
14. Wells A, Fisher P, Myers S, Wheatley J, Patel T, Brewin CR. Metacognitive therapy in recurrent and persistent depression: A multiple-baseline study of a new treatment. Cognitive Therapy and Research. 2009 Jun 1;33(3):291-300. https://doi.org/10.1007/s10608-007-9178-2
https://doi.org/10.1007/s10608-007-9178-2
 
15. Dimidjian S, Barrera Jr M, Martell C, Munoz RF, Lewinsohn PM. The origins and current status of behavioral activation treatments for depression. Annual review of clinical psychology. 2011 Apr 27;7:1-38.
https://doi.org/10.1146/annurev-clinpsy-032210-104535
PMid:21275642
 
16. Dichter GS, Felder JN, Smoski MJ. The effects of brief behavioral activation therapy for depression on cognitive control in affective contexts: an fMRI investigation. Journal of affective disorders. 2010 Oct 1;126(1-2):236-44.
https://doi.org/10.1016/j.jad.2010.03.022
PMid:20421135 PMCid:PMC2929307
 
17. Rochat L, Manolov R, Billieux J. Efficacy of metacognitive therapy in improving mental health: A meta‐analysis of single‐case studies. Journal of clinical psychology. 2018 Jun;74(6):896-915.
https://doi.org/10.1002/jclp.22567
PMid:29266265
 
18. Wells A, Colbear JS. Treating posttraumatic stress disorder with metacognitive therapy: a preliminary controlled trial. Journal of Clinical Psychology. 2012 Apr;68(4):373-81.
https://doi.org/10.1002/jclp.20871
PMid:24469928
 
19. Fisher PL, Byrne A, Fairburn L, Ullmer H, Abbey G, Salmon P. Brief metacognitive therapy for emotional distress in adult cancer survivors. Frontiers in psychology. 2019;10.
https://doi.org/10.3389/fpsyg.2019.00162
PMid:30766505 PMCid:PMC6365419
 
20. Pagoto S, Schneider KL, Whited MC, Oleski JL, Merriam P, Appelhans B, Ma Y, Olendzki B, Waring ME, Busch AM, Lemon S. Randomized controlled trial of behavioral treatment for comorbid obesity and depression in women: the Be Active Trial. International journal of obesity. 2013 Nov;37(11):1427.
https://doi.org/10.1038/ijo.2013.25
PMid:23459323 PMCid:PMC3675166
 
21. Hopko DR, Magidson JF, Lejuez CW. Treatment failure in behavior therapy: Focus on behavioral activation for depression. Journal of clinical psychology. 2011 Nov;67(11):1106-16.
https://doi.org/10.1002/jclp.20840
PMid:21953441
 
22. Nordahl HM, Wells A. Metacognitive Therapy of Early Traumatized Patients With Borderline Personality Disorder: A Phase-II Baseline Controlled Trial. Frontiers in psychology. 2019 Jul 30;10:1694.
https://doi.org/10.3389/fpsyg.2019.01694
PMid:31417453 PMCid:PMC6682682
 
23. Normann N, Morina N. The efficacy of metacognitive therapy: a systematic review and meta-analysis. Frontiers in Psychology. 2018;9:2211.
https://doi.org/10.3389/fpsyg.2018.02211
PMid:30487770 PMCid:PMC6246690
 
24. Strand ER, Hagen R, Hjemdal O, Kennair LE, Solem S. Metacognitive Therapy for Depression Reduces Interpersonal Problems: Results From a Randomized Controlled Trial. Frontiers in psychology. 2018;9:1415.
https://doi.org/10.3389/fpsyg.2018.01415
PMid:30131749 PMCid:PMC6090231
 
25. Jakupcak M, Wagner A, Paulson A, Varra A, McFall M. Behavioral activation as a primary care‐based treatment for PTSD and depression among returning veterans. Journal of Traumatic Stress. 2010 Aug;23(4):491-5.
https://doi.org/10.1002/jts.20543
PMid:20623596
 
26. Chen J, Liu X, Rapee RM, Pillay P. Behavioural activation: A pilot trial of transdiagnostic treatment for excessive worry. Behaviour Research and Therapy. 2013 Sep 1;51(9):533-9.
https://doi.org/10.1016/j.brat.2013.05.010
PMid:23827657
 
27. Bot M, Brouwer IA, Roca M, Kohls E, Penninx BW, Watkins E, Van Grootheest G, Cabout M, Hegerl U, Gili M, Owens M. Effect of multinutrient supplementation and food-related behavioral activation therapy on prevention of major depressive disorder among overweight or obese adults with subsyndromal depressive symptoms: the MooDFOOD randomized clinical trial. Jama. 2019 Mar 5;321(9):858-68.
https://doi.org/10.1001/jama.2019.0556
PMid:30835307 PMCid:PMC6439597
 
28. Reynolds EK, MacPherson L, Tull MT, Baruch DE, Lejuez CW. Integration of the brief behavioral activation treatment for depression (BATD) into a college orientation program: Depression and alcohol outcomes. Journal of counseling psychology. 2011 Oct;58(4):555.
https://doi.org/10.1037/a0024634
PMid:21787070 PMCid:PMC4104126
 
29. Jordan J, Carter JD, McIntosh VV, Fernando K, Frampton CM, Porter RJ, Mulder RT, Lacey C, Joyce PR. Metacognitive therapy versus cognitive behavioural therapy for depression: a randomized pilot study. Australian & New Zealand Journal of Psychiatry. 2014 Oct;48(10):932-43.
https://doi.org/10.1177/0004867414533015
PMid:24810871
Razavi International Journal of Medicine
Volume 9, Issue 3
July 2021
Pages 18-24

Files

Share

How to cite

Statistics